+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bifurcation Stent Market by Product Type (Bare Metal Stent, Bioabsorbable Stent, Drug Eluting Stent), Material Type (Cobalt Chromium, Polymer Scaffold, Stainless Steel), Implantation Technique, Application, End User - Global Forecast 2025-2030- Product Image
Bifurcation Stent Market by Product Type (Bare Metal Stent, Bioabsorbable Stent, Drug Eluting Stent), Material Type (Cobalt Chromium, Polymer Scaffold, Stainless Steel), Implantation Technique, Application, End User - Global Forecast 2025-2030- Product Image
New

Bifurcation Stent Market by Product Type (Bare Metal Stent, Bioabsorbable Stent, Drug Eluting Stent), Material Type (Cobalt Chromium, Polymer Scaffold, Stainless Steel), Implantation Technique, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6133507
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Coronary bifurcation lesions present one of the most intricate challenges in interventional cardiology, demanding tailored device designs and procedural protocols. These anatomical complexities influence blood flow dynamics and predispose patients to restenosis, prompting clinicians and manufacturers to innovate advanced stent architectures and surface modifications. As patient populations age and comorbidities such as diabetes become more prevalent, the imperative to address bifurcations with precision and durability has intensified.

Recent years have witnessed an evolution from traditional bare metal scaffolds to polymer-based and drug eluting technologies that mitigate neointimal hyperplasia. Device performance now hinges on optimal radial strength combined with minimal strut thickness, ensuring access to side branches without compromising vessel patency. Emerging materials and biodegradable platforms further underscore the drive toward scaffolds that balance acute procedural success with long-term vessel healing.

This executive summary synthesizes the latest trends and strategic considerations shaping the bifurcation stent arena. We explore technological breakthroughs, assess trade headwinds and regulatory impacts, dissect segmentation insights across product, material, technique, application and end user dimensions, and deliver actionable recommendations. By understanding these facets, stakeholders can navigate complexity and harness opportunities within this specialized vascular intervention segment.

Examining the Transformational Shifts Reshaping the Bifurcation Stent Landscape through Innovation and Care Pathway Integration

The bifurcation stent sector is undergoing a profound transformation, driven by converging technological, procedural, and clinical shifts. Advances in imaging modalities such as three-dimensional intravascular ultrasound and high-resolution optical coherence tomography have enabled precise lesion characterization. These developments empower interventionalists to tailor stent placement and optimize outcomes by visualizing side branch ostia in real time.

Additionally, the integration of computational fluid dynamics into device design has led to strut patterns that minimize flow disturbance and reduce shear stress at bifurcation points. Simultaneously, the emergence of bioresorbable scaffolds is redefining vessel healing pathways, offering temporary support while gradually relinquishing mechanical presence to restore natural vasomotion.

Patient-centric care models are also reshaping procedural choices, with multidisciplinary heart teams evaluating risk factors to select dedicated bifurcation techniques or provisional approaches. Digital platforms for remote monitoring and data analytics are fostering iterative learning cycles, wherein real-world performance informs next-generation iterations. Collectively, these shifts underscore a dynamic landscape where innovation and personalized therapy converge.

Assessing the Far-Reaching Consequences of the 2025 United States Tariff Regime on Bifurcation Stent Supply and Development

The introduction of new tariff measures by the United States in 2025 has exerted a multifaceted effect on the bifurcation stent market. Increased duties on imported components have elevated manufacturing costs, prompting supply chain realignment and cost reengineering across product portfolios. Original equipment manufacturers have responded by diversifying sourcing strategies, exploring regional suppliers and nearshoring critical alloy and polymer inputs to mitigate exposure to tariff volatility.

Furthermore, these trade adjustments have influenced pricing negotiations with healthcare providers, compelling device companies to demonstrate value through improved clinical performance and long-term cost savings. In parallel, regulatory submissions and approval timelines have been recalibrated to account for component substitutions and design modifications necessitated by alternative material selections. These adaptations have underscored the need for robust quality management systems and proactive engagement with regulatory authorities.

Despite these headwinds, the tariff landscape has also accelerated strategic partnerships among manufacturers and contract development organizations, fostering collaborative innovation to streamline production workflows and control margin pressures. This evolving environment highlights the critical interplay between global trade policy and the advancement of specialized stent technologies.

Uncovering Critical Insights across Product, Material, Technique, Application, and End User Segmentation to Drive Bifurcation Stent Strategy

A nuanced understanding of market segmentation reveals pivotal insights for strategic positioning. Product type analysis encompasses traditional bare metal stents, an expanding segment of bioabsorbable scaffolds, and diverse drug eluting stents. Within the latter category, everolimus eluting platforms, paclitaxel eluting variants, and sirolimus eluting constructs incorporate either biodegradable or durable polymer matrices to tailor drug release kinetics and vessel healing profiles.

Material composition plays an equally critical role, with cobalt chromium alloys offering superior radial strength, stainless steel providing proven biocompatibility, and novel polymer scaffold approaches enabling full bioresorption. Implantation techniques further differentiate offerings: dedicated bifurcation stenting approaches such as crush, culotte, T stenting with minimal protrusion, and V stenting stand alongside provisional methods that reserve side branch access for necessity.

Clinical applications span interventions for coronary artery disease as well as select peripheral artery scenarios, while the end user landscape extends from streamlined procedures conducted in ambulatory surgical centers to complex interventions in hospital catheterization labs. Each segmentation dimension informs product development roadmaps, market entry tactics, and tailored value propositions to address specific clinical and operational requirements.

Illuminating Regional Dynamics and Growth Drivers across the Americas, Europe Middle East Africa, and Asia Pacific Bifurcation Stent Markets

Regional dynamics exert a profound influence on bifurcation stent adoption and growth patterns. The Americas region demonstrates robust demand driven by a mature healthcare infrastructure, well-established reimbursement frameworks, and a high procedural volume of percutaneous coronary interventions. North American markets prioritize premium device features and rapid integration of novel technologies following regulatory approval.

In Europe, Middle East & Africa, collaborative regulatory pathways and pan-European clinical studies facilitate harmonized market access, while emerging economies within the region present expansion opportunities as healthcare spending accelerates. Localized clinical guidelines and reimbursement models shape purchasing decisions, with cross-border partnerships promoting knowledge exchange and best practice dissemination.

Asia-Pacific markets are propelled by expanding hospital networks, rising cardiovascular disease prevalence, and increasing investment in advanced interventional cardiology. Governments in key markets are introducing incentives to adopt cutting-edge medical technologies, fostering an environment where both global and regional players can introduce bifurcation stent innovations tailored to diverse patient populations.

Revealing Strategic Moves and Innovation Trajectories of Leading Bifurcation Stent Manufacturers Shaping Competitive Advantage

Leading companies in the bifurcation stent arena are deploying a range of strategic initiatives to sustain competitive advantage. Established manufacturers are enhancing their portfolios through next-generation drug eluting platforms featuring ultra-thin struts and optimized polymer coatings that enhance biocompatibility and deliver controlled drug release. These firms are also investing in modular delivery systems to streamline operator workflow and reduce procedure times.

Simultaneously, emerging players are forging alliances with research institutions and contract engineering experts to accelerate innovation cycles for bioresorbable scaffolds and hybrid material constructs. Collaborative clinical trials are expanding evidence portfolios that demonstrate superior outcomes in complex bifurcation anatomies, bolstering adoption among high-volume interventional cardiologists.

Strategic acquisitions and licensing agreements have also characterized the competitive landscape, as market incumbents seek to augment their intellectual property assets and geographic reach. These maneuvers underscore a shared recognition that differentiation in the bifurcation segment hinges on a balance of proven efficacy, procedural efficiency, and meaningful improvements in long-term vessel patency.

Formulating Actionable Strategies for Industry Leaders to Capitalize on Emerging Opportunities in the Bifurcation Stent Sector

Industry leaders should prioritize a triad of strategic actions to maximize growth and clinical impact. First, channel investments into advanced research and development programs that refine polymer formulations, optimize drug elution profiles, and leverage computational modeling for strut design. Such efforts will yield devices that address both immediate procedural success and long-term vessel health.

Second, cultivate resilient supply chains by diversifying component sourcing and establishing regional manufacturing partnerships. This approach will mitigate tariff exposure, reduce lead times, and ensure continuity of supply during global disruptions. Concurrently, enhance collaborations with regulatory bodies to anticipate policy changes and streamline approval pathways for design enhancements.

Finally, deepen engagement with interventional cardiology centers of excellence to co-create training modules and real-world evidence studies that validate technique refinements and device performance. This collaborative ecosystem approach will drive clinical adoption, inform iterative product improvements, and position organizations as trusted partners in advancing patient outcomes within the bifurcation domain.

Detailing the Rigorous Research Framework and Robust Methodology Underpinning Comprehensive Bifurcation Stent Market Insights

The research framework underpinning these insights integrated a combination of primary and secondary methodologies to ensure comprehensive coverage and accuracy. In depth interviews were conducted with leading interventional cardiologists, regulatory experts, and industry veterans to capture firsthand perspectives on device performance, procedural preferences, and emerging challenges.

Secondary research encompassed a thorough review of peer-reviewed journals, clinical trial registries, patent databases, and regulatory filings to validate technology trends, material developments, and competitive activities. Quantitative analysis applied data triangulation techniques to reconcile disparate sources and ensure consistency across market segmentation dimensions.

This multilayered approach was further reinforced by statistical validation and expert panel workshops that evaluated preliminary findings, refined analytical models, and ensured the robustness of actionable recommendations. Such methodological rigor provides stakeholders with a reliable foundation for strategic decision-making in the evolving bifurcation stent landscape.

Synthesizing Key Findings and Strategic Imperatives to Propel the Future of Bifurcation Stent Innovation and Adoption

This executive summary has illuminated the confluence of technological innovation, regulatory dynamics, and strategic imperatives that define the bifurcation stent market. From advanced imaging guided procedural refinements to the emergence of bioresorbable scaffold platforms, the domain is characterized by rapid evolution and escalating clinical complexity.

Tariff-driven supply chain realignment, granular segmentation across product and end use dimensions, and region-specific growth trajectories underscore the need for adaptive strategies. Leading manufacturers are differentiating through targeted R&D investments, strategic partnerships, and modular delivery solutions that enhance procedural efficiency and patient outcomes.

As the market matures, future success will hinge on the ability to anticipate policy changes, harness real-world evidence, and maintain a relentless focus on innovation. Organizations that integrate these imperatives into their strategic roadmaps will be best positioned to shape the next chapter of bifurcation stent adoption and deliver meaningful value to clinicians and patients alike.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Bare Metal Stent
    • Bioabsorbable Stent
    • Drug Eluting Stent
      • Everolimus Eluting Stent
        • Biodegradable Polymer
        • Durable Polymer
      • Paclitaxel Eluting Stent
        • Biodegradable Polymer
        • Durable Polymer
      • Sirolimus Eluting Stent
        • Biodegradable Polymer
        • Durable Polymer
  • Material Type
    • Cobalt Chromium
    • Polymer Scaffold
    • Stainless Steel
  • Implantation Technique
    • Dedicated Bifurcation Stenting
      • Crush Technique
      • Culotte Technique
      • T Stenting And Small Protrusion
      • V Stenting
    • Provisional Stenting
  • Application
    • Coronary Artery Disease
    • Peripheral Artery Disease
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Abbott Laboratories
  • Medtronic plc
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG
  • Terumo Corporation
  • Biosensors International Group, Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • OrbusNeich Medical (Group) Co., Ltd.
  • Tryton Medical, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of dedicated bifurcation stents designed for complex coronary lesion anatomies
5.2. Advancements in bioresorbable polymer coatings reducing restenosis rates in bifurcation stenting
5.3. Widening use of intravascular imaging guidance to optimize stent placement in bifurcation lesions
5.4. Emergence of drug coated bifurcation stents featuring ultra thin struts for enhanced deliverability
5.5. Increasing investment in research for polymer free drug elution technologies specific to bifurcation stents
5.6. Growing preference for two stent techniques supported by innovative dedicated bifurcation stent designs
5.7. Expanding adoption of 3D printed coronary models for pre procedural planning in bifurcation interventions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bifurcation Stent Market, by Product Type
8.1. Introduction
8.2. Bare Metal Stent
8.3. Bioabsorbable Stent
8.4. Drug Eluting Stent
8.4.1. Everolimus Eluting Stent
8.4.1.1. Biodegradable Polymer
8.4.1.2. Durable Polymer
8.4.2. Paclitaxel Eluting Stent
8.4.2.1. Biodegradable Polymer
8.4.2.2. Durable Polymer
8.4.3. Sirolimus Eluting Stent
8.4.3.1. Biodegradable Polymer
8.4.3.2. Durable Polymer
9. Bifurcation Stent Market, by Material Type
9.1. Introduction
9.2. Cobalt Chromium
9.3. Polymer Scaffold
9.4. Stainless Steel
10. Bifurcation Stent Market, by Implantation Technique
10.1. Introduction
10.2. Dedicated Bifurcation Stenting
10.2.1. Crush Technique
10.2.2. Culotte Technique
10.2.3. T Stenting And Small Protrusion
10.2.4. V Stenting
10.3. Provisional Stenting
11. Bifurcation Stent Market, by Application
11.1. Introduction
11.2. Coronary Artery Disease
11.3. Peripheral Artery Disease
12. Bifurcation Stent Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Hospitals
13. Americas Bifurcation Stent Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Bifurcation Stent Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Bifurcation Stent Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. Medtronic plc
16.3.3. Boston Scientific Corporation
16.3.4. BIOTRONIK SE & Co. KG
16.3.5. Terumo Corporation
16.3.6. Biosensors International Group, Ltd.
16.3.7. Meril Life Sciences Pvt. Ltd.
16.3.8. Lepu Medical Technology (Beijing) Co., Ltd.
16.3.9. OrbusNeich Medical (Group) Co., Ltd.
16.3.10. Tryton Medical, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BIFURCATION STENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIFURCATION STENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIFURCATION STENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIFURCATION STENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIFURCATION STENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIFURCATION STENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIFURCATION STENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIFURCATION STENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIFURCATION STENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIFURCATION STENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIFURCATION STENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIFURCATION STENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIFURCATION STENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIFURCATION STENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BIFURCATION STENT MARKET: RESEARCHAI
FIGURE 26. BIFURCATION STENT MARKET: RESEARCHSTATISTICS
FIGURE 27. BIFURCATION STENT MARKET: RESEARCHCONTACTS
FIGURE 28. BIFURCATION STENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIFURCATION STENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIFURCATION STENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIFURCATION STENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIFURCATION STENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIFURCATION STENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIFURCATION STENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIFURCATION STENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIFURCATION STENT MARKET SIZE, BY BARE METAL STENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIFURCATION STENT MARKET SIZE, BY BARE METAL STENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIFURCATION STENT MARKET SIZE, BY BIOABSORBABLE STENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIFURCATION STENT MARKET SIZE, BY BIOABSORBABLE STENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIFURCATION STENT MARKET SIZE, BY BIODEGRADABLE POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIFURCATION STENT MARKET SIZE, BY BIODEGRADABLE POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIFURCATION STENT MARKET SIZE, BY DURABLE POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIFURCATION STENT MARKET SIZE, BY DURABLE POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIFURCATION STENT MARKET SIZE, BY BIODEGRADABLE POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIFURCATION STENT MARKET SIZE, BY BIODEGRADABLE POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIFURCATION STENT MARKET SIZE, BY DURABLE POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIFURCATION STENT MARKET SIZE, BY DURABLE POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIFURCATION STENT MARKET SIZE, BY BIODEGRADABLE POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIFURCATION STENT MARKET SIZE, BY BIODEGRADABLE POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIFURCATION STENT MARKET SIZE, BY DURABLE POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIFURCATION STENT MARKET SIZE, BY DURABLE POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIFURCATION STENT MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIFURCATION STENT MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIFURCATION STENT MARKET SIZE, BY POLYMER SCAFFOLD, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIFURCATION STENT MARKET SIZE, BY POLYMER SCAFFOLD, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIFURCATION STENT MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIFURCATION STENT MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIFURCATION STENT MARKET SIZE, BY CRUSH TECHNIQUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIFURCATION STENT MARKET SIZE, BY CRUSH TECHNIQUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIFURCATION STENT MARKET SIZE, BY CULOTTE TECHNIQUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIFURCATION STENT MARKET SIZE, BY CULOTTE TECHNIQUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIFURCATION STENT MARKET SIZE, BY T STENTING AND SMALL PROTRUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIFURCATION STENT MARKET SIZE, BY T STENTING AND SMALL PROTRUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIFURCATION STENT MARKET SIZE, BY V STENTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIFURCATION STENT MARKET SIZE, BY V STENTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIFURCATION STENT MARKET SIZE, BY PROVISIONAL STENTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIFURCATION STENT MARKET SIZE, BY PROVISIONAL STENTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIFURCATION STENT MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIFURCATION STENT MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIFURCATION STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIFURCATION STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIFURCATION STENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIFURCATION STENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIFURCATION STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIFURCATION STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIFURCATION STENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIFURCATION STENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS BIFURCATION STENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS BIFURCATION STENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BIFURCATION STENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BIFURCATION STENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES BIFURCATION STENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES BIFURCATION STENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES BIFURCATION STENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES BIFURCATION STENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 123. CANADA BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. CANADA BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. CANADA BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 126. CANADA BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 127. CANADA BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 128. CANADA BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 129. CANADA BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 130. CANADA BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 131. CANADA BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 132. CANADA BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 133. CANADA BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 134. CANADA BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 135. CANADA BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 136. CANADA BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 137. CANADA BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2018-2024 (USD MILLION)
TABLE 138. CANADA BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2025-2030 (USD MILLION)
TABLE 139. CANADA BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. CANADA BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. CANADA BIFURCATION STENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. CANADA BIFURCATION STENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. MEXICO BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 146. MEXICO BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 147. MEXICO BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 148. MEXICO BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 149. MEXICO BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 150. MEXICO BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 151. MEXICO BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 152. MEXICO BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 153. MEXICO BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 156. MEXICO BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2018-2024 (USD MILLION)
TABLE 158. MEXICO BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2025-2030 (USD MILLION)
TABLE 159. MEXICO BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. MEXICO BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. MEXICO BIFURCATION STENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. MEXICO BIFURCATION STENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL BIFURCATION STENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL BIFURCATION STENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA BIFURCATION STENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA BIFURCATION STENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA BIFURCATION STENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM BIFURCATION STENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. GERMANY BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 248. GERMANY BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 249. GERMANY BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 250. GERMANY BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 251. GERMANY BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 252. GERMANY BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 253. GERMANY BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 254. GERMANY BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 255. GERMANY BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 256. GERMANY BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 257. GERMANY BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 258. GERMANY BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 259. GERMANY BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2018-2024 (USD MILLION)
TABLE 260. GERMANY BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2025-2030 (USD MILLION)
TABLE 261. GERMANY BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. GERMANY BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. GERMANY BIFURCATION STENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. GERMANY BIFURCATION STENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. FRANCE BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. FRANCE BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. FRANCE BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 268. FRANCE BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 269. FRANCE BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 270. FRANCE BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 271. FRANCE BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 272. FRANCE BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 273. FRANCE BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 274. FRANCE BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 275. FRANCE BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 276. FRANCE BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 277. FRANCE BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 278. FRANCE BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 279. FRANCE BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2018-2024 (USD MILLION)
TABLE 280. FRANCE BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2025-2030 (USD MILLION)
TABLE 281. FRANCE BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. FRANCE BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. FRANCE BIFURCATION STENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. FRANCE BIFURCATION STENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA BIFURCATION STENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA BIFURCATION STENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. ITALY BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. ITALY BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. ITALY BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 308. ITALY BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 309. ITALY BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 310. ITALY BIFURCATION STENT MARKET SIZE, BY EVEROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 311. ITALY BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 312. ITALY BIFURCATION STENT MARKET SIZE, BY PACLITAXEL ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 313. ITALY BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 314. ITALY BIFURCATION STENT MARKET SIZE, BY SIROLIMUS ELUTING STENT, 2025-2030 (USD MILLION)
TABLE 315. ITALY BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 316. ITALY BIFURCATION STENT MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 317. ITALY BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 318. ITALY BIFURCATION STENT MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 319. ITALY BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2018-2024 (USD MILLION)
TABLE 320. ITALY BIFURCATION STENT MARKET SIZE, BY DEDICATED BIFURCATION STENTING, 2025-2030 (USD MILLION)
TABLE 321. ITALY BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. ITALY BIFURCATION STENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. ITALY BIFURCATION STENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. ITALY BIFURCATION STENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. SPAIN BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. SPAIN BIFURCATION STENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. SPAIN BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2018-2024 (USD MILLION)
TABLE 328. SPAIN BIFURCATION STENT MARKET SIZE, BY DRUG ELUTING STENT, 2025-2030

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bifurcation Stent market report include:
  • Abbott Laboratories
  • Medtronic plc
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG
  • Terumo Corporation
  • Biosensors International Group, Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • OrbusNeich Medical (Group) Co., Ltd.
  • Tryton Medical, Inc.

Related Topics

Related Reports

Bifurcation Lesions Market by Stent Type (Bare Metal Stents, Drug-Eluting Stents), Stenting Technique (Provisional Stenting, Two Stent Technique), End User, Polymer Type - Global Forecast 2025-2030 - Product Image

Bifurcation Lesions Market by Stent Type (Bare Metal Stents, Drug-Eluting Stents), Stenting Technique (Provisional Stenting, Two Stent Technique), End User, Polymer Type - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Bifurcation Lesions Market Report 2025 - Product Image

Bifurcation Lesions Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Self-Expanding Vascular Stent Market by Material (Cobalt-Chromium, Nitinol, Polymer), Application (Coronary, Neurovascular, Peripheral), Design, End User, Indication, Procedure Type - Global Forecast 2025-2030 - Product Image

Self-Expanding Vascular Stent Market by Material (Cobalt-Chromium, Nitinol, Polymer), Application (Coronary, Neurovascular, Peripheral), Design, End User, Indication, Procedure Type - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Bioabsorbable Sirolimus-eluting Coronary Stent System Market by Product Type (Balloon Expandable, Self Expanding), Indication (Chronic Total Occlusion, Myocardial Infarction, Stable Angina), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Bioabsorbable Sirolimus-eluting Coronary Stent System Market by Product Type (Balloon Expandable, Self Expanding), Indication (Chronic Total Occlusion, Myocardial Infarction, Stable Angina), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Bifurcation Lesions - Global Strategic Business Report - Product Image

Bifurcation Lesions - Global Strategic Business Report

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.